Skip to main content

High Rates of Harassment Behaviors Observed in Obstetrics and Gynecology

Medically reviewed by Carmen Pope, BPharm. Last updated on May 9, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, May 9, 2024 -- There are high rates of harassment behaviors within the obstetrics and gynecology (OB-GYN) specialty, according to a review published online May 8 in JAMA Network Open.

Ankita Gupta, M.D., M.P.H., from the University of Louisville Health in Kentucky, and colleagues conducted a systematic review of the prevalence of sexual harassment, bullying, abuse, and discrimination among OB-GYN clinicians and trainees and reviewed interventions aimed at reducing harassment. Ten studies, with 5,852 participants, addressed prevalence, and 12 studies, involving 2,906 participants, addressed interventions.

The researchers found that OB-GYN respondents frequently reported prevalence of sexual harassment (range, 27.6 percent of physicians to 70.9 percent of female gynecologic oncologists), workplace discrimination (67.2 percent of female versus 38.5 percent of male gynecologic oncologists), and bullying (52.8 percent of female gynecologic oncologists). OB-GYN trainees often experienced sexual harassment (69.1 percent), including gender harassment, unwanted sexual attention, and sexual coercion. About one-quarter of medical students surveyed (25.1 percent) indicated mistreatment during their OB-GYN rotation. Physicians, other trainees, and operating room staff were perpetrators of harassment (30.1, 13.1, and 7.7 percent, respectively). No significant decrease in the frequency of sexual harassment was seen with any intervention.

"Interventions to decrease harassment had not been adequately studied, but institutionwide, multipronged approaches with support from varying levels of stakeholders appeared to have the highest efficacy for reductions in mistreatment in medical training," the authors write. "Nevertheless, most interventions were not associated with reduced sexual harassment."

Several authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Planetary Health Diet Index Linked to Lower Total, Cause-Specific Mortality

MONDAY, June 10, 2024 -- A higher Planetary Health Diet Index (PHDI) is associated with a lower risk for total and cause-specific mortality, according to a study published online...

Prevalence of Iron Deficiency Varies With Different Definitions

MONDAY, June 10, 2024 -- The prevalence of iron deficiency varies significantly with three different definitions, according to a study published online June 7 in JAMA Network...

AI Blood-Based Lung Cancer Screening Test Developed for Fragmentome

MONDAY, June 10, 2024 -- A novel blood-based lung cancer screening test has been developed and validated using genome-wide sequencing to analyze cell-free DNA (cfDNA)...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.